Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Raynier Devillier ,Boris Calmels ,Sophie Guia , Mohammed Taha , Cyril Fauriat , Bechara Mfarrej , Geoffroy Venton , Eric Vivier , Daniel Olive , Christian Chabannon , Didier Blaise ,and Sophie Ugolini

Journal title: Cancers

Journal publisher: Multidisciplinary Digital Publishing Institute (MDPI)

Published year: 2021

DOI identifier: 10.3390/cancers13112673

ISSN: 2072-6694